Literature DB >> 33309183

Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic.

M Machiels1, R Weytjens2, W Bauwens3, W Vingerhoed3, C Billiet2, P Huget3, D Verellen2, P Dirix2, P Meijnders2, P Poortmans2, O Kaidar-Person4.   

Abstract

Entities:  

Year:  2020        PMID： 33309183     DOI： 10.1016/j.clon.2020.11.027

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  4 in total

1.  Expert Discussion: Hypofractionated Radiation Therapy - Standard for All Indications?

Authors:  Gerd Fastner; David Krug; Icro Meattini; Günther Gruber; Philip Poortmans
Journal:  Breast Care (Basel)       Date:  2021-12-20       Impact factor: 2.268

Review 2.  Radiotherapy based management during Covid-19 pandemic - A systematic review of presented consensus and guidelines.

Authors:  Zahra Siavashpour; Neda Goharpey; Mosayyeb Mobasheri
Journal:  Crit Rev Oncol Hematol       Date:  2021-06-30       Impact factor: 6.312

3.  Dosimetric effect of respiratory motion on planned dose in whole-breast volumetric modulated arc therapy using moderate and ultra-hypofractionation.

Authors:  Mikko Mankinen; Tuomas Virén; Jan Seppälä; Heikki Hakkarainen; Tuomas Koivumäki
Journal:  Radiat Oncol       Date:  2022-03-05       Impact factor: 3.481

Review 4.  Covid-19 and radiotherapy: a systematic review after 2 years of pandemic.

Authors:  Antonio Piras; Valeria Venuti; Andrea D'Aviero; Davide Cusumano; Stefano Pergolizzi; Antonino Daidone; Luca Boldrini
Journal:  Clin Transl Imaging       Date:  2022-07-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.